GL1X · GenesisL1 explorer

Research workbench

Crystal structure of mouse galectin-9 N-terminal crd in complex with N-acetyllactosamine dimer

Analyse Crystal structure of mouse galectin-9 N-terminal crd in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2D6O
Type
protein
Length
151 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lectin, galactose binding, soluble 9
UniProt
Q5SXE6
Ligands
NAG, GAL
Pockets
1 · best druggability 0.30

Structure

x-ray diffraction · 1 distinct chain · 2% helix, 56% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
XLectin, galactose binding, soluble 9protein1512% helix, 56% strandQ5SXE6

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains X
  • GAL · beta-D-galactopyranose · sugar · 2 copies · chains X
  • GOL · Glycerol · additive · chains X

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1620.300.7416empty

Compared structures

  • 2D6O · Crystal structure of mouse galectin-9 N-terminal CRD in complex with N-acetyllactosamine… · the same entry in another collection · chain X against X, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.